Notice of Funding Opportunity for Mid-Phase Clinical Trials of Natural Products
National Institutes of Health
Description
The grant opportunity invites applications for mid-phase clinical trials focused on natural products like botanicals, dietary supplements, and probiotics. These trials should be based on solid scientific evidence and preliminary data. The aim is to find the best doses or formulations and understand patient types for future detailed trials. This opportunity does not support trials related to cancer treatment or prevention.
This NOFO encourages applications for mid-phase clinical trials of natural products such as botanicals, dietary supplements, and probiotics. The trials should have a strong scientific premise and be supported by preliminary data. The goal is to determine optimal doses or formulations and identif…
Source
Grant ID
PAR-25-271
Agency
National Institutes of Health
Subcategory/Subagency
National Center for Complementary and Integrative Health
Key Dates
Opportunity Released
December 2, 2024
Eligibility
The following categories of applicants are invited to apply:
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Local Governments (General)
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Governments (Federally Recognized)
- Native American Tribal Governments (Other than Federally Recognized)
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession Governments/Entities
- Faith-based or Community-based Organizations
- Regional Organizations
Awards & Funding
Total Funding
$350,000
Funding Amount
Discretionary
Similar opportunities
- Investigator-Initiated Early Phase Clinical Trials of Natural Products (R61/R33 Clinical Trial Required)
National Institutes of Health
- Investigator-Initiated Multi-Site Clinical Trials of Natural Products (UG3/UH3 Clinical Trial Required)
National Institutes of Health
- Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
National Institutes of Health
- Investigator-Initiated Clinical Trials of Complementary and Integrative Health Approaches
National Institutes of Health
- Notice of Funding Opportunity Purpose
National Institutes of Health